Overview
Discounted cash flow
Income / accounting-based
Multiples & assets
Scenario
Toolbox
Weighted blend
$679.98
+72.94% vs spot
Strong Buy
Spot price
$393.19
Mkt cap $85.39B
subtle cardAnalyst PT consensus
$382.38
-2.75% vs spot
subtle cardMethods covered
20 / 21
17 in blend
subtle cardFootball field
ELV · fair-value range by method
Method comparison
ELV · fair value by valuation framework
| Method | Category | Fair value | Range | vs spot | Weight | Driver | Conf. |
|---|---|---|---|---|---|---|---|
| DCF · FCFF | dcf | $774.80 | $442.85 – $2,085.33 | +97.05% | 19.9% | WACC 5.8%, g₀=4.7%, gₗ=3.9% | high |
| DCF · FCFE | dcf | $294.24 | $221.23 – $468.82 | -25.17% | 14.9% | kₑ 7.5%, g₀=4.7%, gₗ=3.9% | high |
| DDM · Gordon | ddm | $217.56 | $169.72 – $302.96 | -44.67% | — | D₁ 7.43, kₑ 7.5%, gₗ 3.9% | med |
| DDM · H-model | ddm | $226.33 | $169.72 – $358.91 | -42.44% | — | D₀ 7.43, g₀=4.7%, gₗ=3.9%, H 5y | med |
| DDM · multi-stage | ddm | $221.83 | $188.56 – $255.11 | -43.58% | 5.0% | 5y schedule 4.7% → 3.9%, kₑ 7.5% | high |
| Residual income | income | $241.16 | $212.22 – $270.10 | -38.66% | 10.0% | BV 213.89, ROE 12.9% → kₑ | high |
| EVA / MVA | income | $1,081.22 | $951.47 – $1,210.97 | +174.99% | 7.0% | IC 67.8B, WACC 5.8% | high |
| Justified P/E | multiple | $262.15 | $222.83 – $301.47 | -33.33% | 6.0% | Fair P/E 10.4 (payout 27%, kₑ 7.5%, g 4.7%) | med |
| P/E · sector | multiple | $552.64 | $486.32 – $618.96 | +40.55% | 11.9% | EPS 25.12 × peer P/E 22.0 | med |
| Justified P/B | multiple | $640.66 | $544.56 – $736.76 | +62.94% | 5.0% | Fair P/B 3.00 · ROE 12.9%, kₑ 7.5% | high |
| P/S · sector | multiple | $3,869.61 | $3,289.17 – $4,450.06 | +884.16% | 3.0% | Rev/sh 967.40 × peer P/S 4.00 | med |
| EV / EBITDA | multiple | $588.46 | $517.85 – $659.08 | +49.66% | 10.0% | EBITDA × peer 15.0× − ND 23.7B | high |
| EV / EBIT | multiple | $594.03 | $504.93 – $683.14 | +51.08% | 2.0% | EBIT × peer 18.0× − ND | med |
| EV / Sales | multiple | $3,173.82 | $2,697.74 – $3,649.89 | +707.20% | 2.0% | Sales × peer 3.40× − ND | med |
| PEG-anchored | multiple | $172.84 | $146.91 – $198.76 | -56.04% | 1.0% | PEG=1, fwd EPS g 6.9% | med |
| Earnings power | intrinsic | $459.46 | $404.33 – $514.60 | +16.86% | 0.5% | NOPAT / WACC, no growth | med |
| Graham revised | intrinsic | $445.70 | $378.84 – $512.55 | +13.35% | 0.5% | EPS×(8.5+2g)·4.4/Y | low |
| Lynch P/E=g | intrinsic | $125.60 | $106.76 – $144.44 | -68.06% | 0.5% | PE = g (4.7) | low |
| Book NAV | asset | $213.89 | $203.20 – $224.58 | -45.60% | 1.0% | (Assets − Liabilities) / Shares | high |
| Liquidation | asset | $50.65 | $43.05 – $58.25 | -87.12% | — | Cash 100% + non-cash 70% − Liab. | low |
| Reverse DCF | reverse | — | — | — | — | Implied g -6.2% · Pessimistic — market pricing decline | high |
Cost-of-capital build-up
CAPM cost of equity, after-tax cost of debt, WACC. Risk-free as of 2026-05-12.
| Risk-free rate (US 10y Treasury)rf | 4.46% |
| Equity beta (0.67)β | × 0.67 |
| Equity risk premiumERP | 4.46% |
| Cost of equity (CAPM)kₑ | 7.45% |
| Pre-tax cost of debtkd | 4.22% |
| Effective tax ratet | 15.8% |
| After-tax cost of debt | 3.55% |
| Equity weight$44.0B | 57.0% |
| Debt weight$33.2B | 43.0% |
| WACC | 5.78% |
Growth assumptions
Blended forward growth used as DCF default; terminal pegged to long-run nominal GDP.
| Analyst forward revenue growthFMP | -2.12% |
| Analyst forward EPS growthFMP | 6.88% |
| Historical 5y revenue CAGRFY | 9.47% |
| Historical 5y EPS CAGRFY | 0.39% |
| Sustainable g (ROE × retention)Δ | 9.39% |
| Blended near-term growth (g₀) | 4.74% |
| Terminal growth (gₗ) | 3.91% |
Sources
- FMP /analyst-estimates— 8 rows(as of 2023-12-31)
- Treasury rates · 10y— 4.46% rf(as of 2026-05-12)
- market_risk_premium · DB— 4.46% ERP(as of 2026-05-13)
- Sector multiple defaults— Healthcare (live sector PE unavailable)
- FMP /price-target-consensus— mean $382.38
This page is generated by a quantitative valuation engine for research purposes only and does not constitute investment advice. Methodology follows standard CFA / Damodaran frameworks; assumptions are driven by analyst consensus from Financial Modeling Prep and reported financial statements.